Regrow Biosciences gets USFDA Nod for Phase II trials of ‘OSSGROW’ for Osteonecrosis in the US
OSSGROW is India’s first FDA (DCGI) approved product that has treated over 1000 patients across 200 hospitals in the country…
Breaking News, English News, Latest Updates, Top Headlines, Real-Time News, Daily News, Trusted News, News Portal, Global News, Unbiased Updates, Comprehensive News,
OSSGROW is India’s first FDA (DCGI) approved product that has treated over 1000 patients across 200 hospitals in the country…